PharmAla Received Guidance on ALA-002 from MHRA; Launches Clinical Program with University of Sydney
Utilizing Advice from the UK’s Medicines and Healthcare Regulatory Agency, PharmAla to move forward on Clinical TrialsVANCOUVER, British Columbia, July 20, 2023 -- PharmAla Biotech Holdings Inc. ...
Source: marketscreener.com